• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国产碳青霉烯酶肠杆菌科细菌:国家实验室监测系统的报告。

Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System.

机构信息

Department of Laboratory Medicine & Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, South Korea.

Division of Antimicrobial Resistance, National Institute of Health, Centers for Disease Control & Prevention, Cheongju, South Korea.

出版信息

Future Microbiol. 2018 Jun 1;13:771-783. doi: 10.2217/fmb-2018-0022. Epub 2018 Feb 26.

DOI:10.2217/fmb-2018-0022
PMID:29478336
Abstract

AIM

To assess the epidemiology of carbapenemase-producing Enterobacteriaceae (CPE) in South Korea.

MATERIALS & METHODS: From 2011 to 2015, 2487 carbapenem-nonsusceptible Enterobacteriaceae were collected through the Korean National Laboratory Surveillance System. Disk-diffusion for antimicrobial susceptibility, PCR/sequencing to detect carbapenemase genes and multilocus sequence typing for molecular epidemiology were carried out.

RESULTS

The number of carbapenem-nonsusceptible Enterobacteriaceae was increasing approximately 1.5-fold per year and the proportion of CPEs was exponentially confirmed from 2014. KPC was the most dominant, mostly associated with Klebsiella pneumoniae ST11 and ST307, NDM was the second and OXA-48-like was the third dominant carbapenemases. The IMP, VIM and GES-5 CPEs were identified sporadically.

CONCLUSION

The nation-wide spreads of KPC, NDM and OXA-48-like CPEs were in an alarming epidemiological stage.

摘要

目的

评估韩国产碳青霉烯酶肠杆菌科(CPE)的流行病学情况。

材料与方法

2011 年至 2015 年,通过韩国国家实验室监测系统收集了 2487 株对碳青霉烯类药物不敏感的肠杆菌科细菌。进行了药敏纸片扩散法、PCR/测序检测碳青霉烯酶基因和多位点序列分型进行分子流行病学研究。

结果

碳青霉烯类药物不敏感肠杆菌科细菌的数量每年增加约 1.5 倍,2014 年以来 CPE 的比例呈指数级增长。KPC 是最主要的,主要与肺炎克雷伯菌 ST11 和 ST307 相关,NDM 是第二大,OXA-48 样酶是第三大主要碳青霉烯酶。IMP、VIM 和 GES-5 产碳青霉烯酶肠杆菌科细菌则是零星出现。

结论

全国范围内 KPC、NDM 和 OXA-48 样 CPE 的传播处于令人警惕的流行阶段。

相似文献

1
Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System.韩国产碳青霉烯酶肠杆菌科细菌:国家实验室监测系统的报告。
Future Microbiol. 2018 Jun 1;13:771-783. doi: 10.2217/fmb-2018-0022. Epub 2018 Feb 26.
2
Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.2017 年至 2018 年期间,三家韩国三级保健大学医院中产碳青霉烯酶肠杆菌科的流行情况和特征。
Jpn J Infect Dis. 2020 Nov 24;73(6):431-436. doi: 10.7883/yoken.JJID.2020.043. Epub 2020 May 29.
3
Molecular characterization of carbapenem-resistant and emergence of tigecycline non-susceptible strains in the Henan province in China: a multicentrer study.中国河南省耐碳青霉烯类和替加环素不敏感菌株的分子特征:一项多中心研究。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001325. Epub 2021 Feb 15.
4
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.头孢他啶-阿维巴坦对西班牙感染-碳青霉烯类耐药评估监测试验(iCREST)中尿液标本中产碳青霉烯酶肠杆菌科的活性。
Int J Antimicrob Agents. 2018 Mar;51(3):511-515. doi: 10.1016/j.ijantimicag.2018.01.011. Epub 2018 Jan 31.
5
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla and bla .肠杆菌科碳青霉烯类耐药菌在两所伊朗大学医院住院患者中的携带情况的分子特征:同时产生 bla 和 bla 的首次报告
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2127-2135. doi: 10.1007/s10096-017-3035-3. Epub 2017 Jun 21.
6
Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.韩国五家医院产碳青霉烯酶肠杆菌科细菌的流行情况及分子特征
Ann Lab Med. 2016 Nov;36(6):529-35. doi: 10.3343/alm.2016.36.6.529.
7
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).碳青霉烯类耐药肠杆菌科的表型和基因型特征:来自中国一项纵向大规模 CRE 研究的数据(2012-2016 年)。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205. doi: 10.1093/cid/ciy660.
8
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.2015 年美罗培南/沃诺拉赞监测项目中耐碳青霉烯肠杆菌科细菌的美罗培南/沃诺拉赞体外活性和碳青霉烯耐药机制特征。
Int J Antimicrob Agents. 2018 Aug;52(2):144-150. doi: 10.1016/j.ijantimicag.2018.02.021. Epub 2018 Mar 3.
9
Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.约旦安曼患者中产碳青霉烯酶肠杆菌科细菌的特征分析
Microb Drug Resist. 2018 Oct;24(8):1121-1127. doi: 10.1089/mdr.2017.0238. Epub 2018 Mar 8.
10
Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014.亚胺培南对2008年至2014年SMART全球监测项目收集的产碳青霉烯酶肠杆菌科分离株的活性。
J Clin Microbiol. 2017 Jun;55(6):1638-1649. doi: 10.1128/JCM.02316-16. Epub 2017 Mar 15.

引用本文的文献

1
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023.2010 - 2023年加拿大急症护理机构中产碳青霉烯酶肠杆菌科细菌的流行病学演变
Antimicrob Resist Infect Control. 2025 Jul 12;14(1):88. doi: 10.1186/s13756-025-01602-w.
2
Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne subsp. from Kolkata, India during 2015-2024: Emergence of subsp. with , , and triple carbapenemases.2015年至2024年期间来自印度加尔各答的产KPC-2血源亚种的抗菌药物耐药性和系统发育谱系:具有NDM-1、IMP-1和VIM-2三重碳青霉烯酶的亚种的出现。
Microbiol Spectr. 2025 Jun 12:e0012625. doi: 10.1128/spectrum.00126-25.
3
Genomic analysis of carbapenem-resistant blood isolates from nationwide surveillance in South Korea.
韩国全国监测中耐碳青霉烯类血液分离株的基因组分析。
Front Microbiol. 2025 May 6;16:1562222. doi: 10.3389/fmicb.2025.1562222. eCollection 2025.
4
Extended-Spectrum Beta-Lactamase- and Plasmidic AmpC-Producing among the Faecal Samples in the Bulgarian Community.保加利亚社区粪便样本中产超广谱β-内酰胺酶和质粒介导的AmpC酶情况
Microorganisms. 2024 Aug 28;12(9):1777. doi: 10.3390/microorganisms12091777.
5
Whole genome structure and resistance genes in carbapenemase-producing multidrug resistant ST378 Klebsiella pneumoniae.产碳青霉烯酶多药耐药 ST378 肺炎克雷伯菌的全基因组结构和耐药基因。
BMC Microbiol. 2023 Nov 3;23(1):323. doi: 10.1186/s12866-023-03074-7.
6
Genomic molecular epidemiology of carbapenemase-producing Escherichia coli ST410 isolates by complete genome analysis.通过全基因组分析研究产碳青霉烯酶大肠埃希菌 ST410 分离株的基因组分子流行病学。
Vet Res. 2023 Sep 1;54(1):72. doi: 10.1186/s13567-023-01205-6.
7
Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea.韩国某地方三甲医院高风险克隆 ST147 碳青霉烯类耐药肺炎克雷伯菌的传播。
Ann Clin Microbiol Antimicrob. 2023 Aug 24;22(1):76. doi: 10.1186/s12941-023-00601-2.
8
Cracking the Code: Unveiling the Diversity of Carbapenem-Resistant Clones in the Arabian Peninsula through Genomic Surveillance.破解密码:通过基因组监测揭示阿拉伯半岛耐碳青霉烯克隆的多样性
Antibiotics (Basel). 2023 Jun 21;12(7):1081. doi: 10.3390/antibiotics12071081.
9
Outbreak of carbapenem-resistant Enterobacterales at a long-term care facility in Seoul, Korea: surveillance and intervention mitigation strategies.韩国首尔一家长期护理机构爆发碳青霉烯类耐药肠杆菌科细菌:监测和干预缓解策略。
Epidemiol Health. 2023;45:e2023057. doi: 10.4178/epih.e2023057. Epub 2023 Jun 9.
10
Genomic Epidemiology and Characterization of Carbapenem-Resistant Klebsiella pneumoniae in ICU Inpatients in Henan Province, China: a Multicenter Cross-Sectional Study.中国河南省 ICU 住院患者耐碳青霉烯类肺炎克雷伯菌的基因组流行病学和特征:一项多中心横断面研究。
Microbiol Spectr. 2023 Jun 15;11(3):e0419722. doi: 10.1128/spectrum.04197-22. Epub 2023 May 22.